Barriga, Danver Kayle .
HRN: 23-82-24 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/06/2025
CEFUROXIME 1.5GM (VIAL)
11/06/2025
11/13/2025
IV DRIP
375mg
Q8
Acute Respiratory Tract Infection
Waiting Final Action
Indication: Empiric Type of Infection: URTI Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes